Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 2134 pages
Exam (elaborations)

Karch's Focus on Nursing Pharmacology 9th Edition Test Bank: Chapter-by-Chapter Exam Prep

Document preview thumbnail
Preview 4 out of 2134 pages

Karch's Focus on Nursing Pharmacology 9th Edition Test Bank: Chapter-by-Chapter Exam Prep SEO Description Master pharmacology with this comprehensive test bank for Karch's Focus on Nursing Pharmacology, 9th Edition by Rebecca G. Tucker. This chapter-by-chapter resource delivers over 1,000 NCLEX-RN and Next Generation NCLEX® (NGN)-style questions covering pharmacokinetics, pharmacodynamics, medication safety, prototype drugs, drug classifications, and adverse effect recognition. Build clinical judgment with realistic case studies, SATA, prioritization, and delegation scenarios. Master cardiovascular, CNS, endocrine, respiratory, GI, anti-infective, and oncology pharmacology. Includes detailed rationales, dosage calculations, and lifespan considerations for pediatric, geriatric, pregnancy, and lactation populations. Ideal for nursing students, educators, and NCLEX-RN candidates seeking high-quality remediation. Strengthen patient education, therapeutic monitoring, and safe medication administration skills. The ultimate resource for nursing pharmacology exam success and NCLEX readiness. SEO Keywords Karch Focus on Nursing Pharmacology 9th Edition Test Bank NCLEX-RN Pharmacology Questions and Answers Next Generation NCLEX NGN Pharmacology Study Guide Nursing Pharmacology Exam Prep Chapter by Chapter Medication Safety and Clinical Judgment Test Bank Pharmacokinetics and Drug Interactions Nursing Review Cardiovascular and CNS Pharmacology NCLEX Practice

Content preview

Karch’s Focus on Nursing
Pharmacology
9th Edition
 Author(s)Rebecca G. Tucker



TEST BANK




Question 1
Clinical Scenario
A nursing student is reviewing the development process for a
new investigational drug. The drug has successfully completed

,preclinical trials and is now being tested in a small group of
healthy volunteers to determine its safety profile, dosage range,
and pharmacokinetics.
Question
In which phase of drug evaluation is this investigational drug
currently being studied?
Options
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Correct Answer
A. Phase I
Rationale
Phase I studies are the first stage of testing in humans and
involve a small number of healthy volunteers (20-80). The
primary goal is to determine the drug's safety, safe dosage
range, and pharmacokinetic profile (how the drug is absorbed,
distributed, metabolized, and excreted).
Why the Other Options Are Incorrect
A. Phase I is correct as described.
B. Phase II studies involve a larger group of patients (100-300)
with the target disease to evaluate effectiveness and further
assess safety.

,C. Phase III studies involve large patient populations (1000-
3000) to confirm effectiveness, monitor adverse effects, and
compare the drug to standard treatments.
D. Phase IV studies are post-marketing surveillance trials that
occur after the drug has been approved by the FDA to monitor
for rare or long-term adverse effects.
Learning Objective
Identify the four phases of clinical drug trials and their primary
objectives.
Bloom's Taxonomy
Remember
Difficulty
Easy
NCLEX Client Needs Category
Pharmacological and Parenteral Therapies
NCJMM Clinical Judgment Skill
Recognize Cues


Question 2
Clinical Scenario
A nurse is preparing to administer a medication to a patient
who is 8 weeks pregnant. The patient asks if the medication is
safe for her baby. The nurse reviews the drug label and notes it

, contains a category that indicates adequate and well-controlled
studies in pregnant women have failed to demonstrate a risk to
the fetus.
Question
Which FDA pregnancy safety category would the nurse identify
on the drug label?
Options
A. Category A
B. Category B
C. Category C
D. Category X
Correct Answer
A. Category A
Rationale
FDA Pregnancy Category A indicates that adequate and well-
controlled studies in pregnant women have failed to
demonstrate a risk to the fetus in the first trimester (and there
is no evidence of risk in later trimesters). This is the safest
category.
Why the Other Options Are Incorrect
A. Category A is correct.
B. Category B indicates animal studies show no risk, but there
are no adequate human studies, or animal studies show risk but
human studies do not.

Connected book
 image
Publisher: Unknown ISBN: 9781975180409 Edition: Unknown

Document information

Uploaded on
June 26, 2026
Number of pages
2134
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$35.49

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
0
Followers
0
Items
93
Last sold
-


Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions